Prognostic significance of VEGF and components of the plasminogen activator system in endometrial cancer

Autor: Paul N. Span, Fred C.G.J. Sweep, Petra L.M. Zusterzeel, Rob van der Steen, Anneke Geurts-Moespot, Karin Abbink

Publikováno v: Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology, 146, 1725-1735
Journal of Cancer Research and Clinical Oncology, 146, 7, pp. 1725-1735

Objective The plasminogen activator system (PAS) and vascular endothelial growth factor (VEGF) are important in the carcinogenesis and play a key role in cancer invasion and mediating metastasis of carcinomas. The aim of the study was to evaluate the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ac65450cf7e43c0dd04c831f42241c1
https://pubmed.ncbi.nlm.nih.gov/32394054

Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials

Autor: Dorine W. Swinkels, Colin I. Cercamondi, Christophe Zeder, Diego Moretti, Nicole U. Stoffel, Anneke Geurts-Moespot, Michael B. Zimmermann, Gary M. Brittenham

Publikováno v: Lancet Haematology, 4, 11, pp. 524-533
Lancet Haematology, 4, 524-533

Summary Background Current guidelines to treat iron deficiency recommend daily provision of ferrous iron divided through the day to increase absorption. However, daily dosing and split dosing might increase serum hepcidin and decrease iron absorption

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce0001cd0d1e33c7c650b0479e920d69
https://doi.org/10.1016/s2352-3026(17)30182-5

Effects of Weekly Iron and Folic Acid Supplements on Malaria Risk in Nulliparous Women in Burkina Faso: A Periconceptional, Double-Blind, Randomized Controlled Noninferiority Trial

Autor: Brian Faragher, Halidou Tinto, Dorine W. Swinkels, Sabine Gies, Salou Diallo, Yves Claeys, Adama Kazienga, Bernard J. Brabin, Sayouba Ouedraogo, Matthew Powney, Anneke Geurts-Moespot, Stephen A Roberts, Umberto D'Alessandro, Loretta Brabin

Publikováno v: The Journal of Infectious Diseases, 218, 7, pp. 1099-1109
The Journal of Infectious Diseases, 218, 1099-1109
The Journal of Infectious Diseases
Gies, S, Diallo, S, Roberts, S A, Kazienga, A, Powney, M, Brabin, L, Ouedraogo, S, Swinkels, D W, Geurts-Moespot, A J, Claeys, Y, D'Alessandro, U, Tinto, H, Faragher, B & Brabin, B 2018, ' Effects of weekly iron and folic acid supplements on malaria risk in nulliparous women in Burkina Faso : A periconceptional, double-blind, randomized controlled noninferiority trial ', Journal of INfectious Diseases, vol. 218, no. 7, pp. 1099-1109 . https://doi.org/10.1093/infdis/jiy257

Weekly iron supplementation, given to young nulliparous women living in a malaria-endemic area, neither improved iron status nor increased malaria risk, suggesting that current iron recommendations may need revisiting for these women.
Background

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::649d66994cfbbe0eec6643fea1e56ce0
https://hdl.handle.net/2066/195586

Donation intensity and metabolic syndrome in active whole-blood donors

Autor: Karlijn Peffer, Anneke Geurts-Moespot, André L. M. Verbeek, M. den Heijer, Femke Atsma, Dorine W. Swinkels

Publikováno v: Vox Sanguinis, 109, 25-34
Peffer, K, Verbeek, A L M, Swinkels, D W, Geurts-Moespot, A J, den Heijer, M & Atsma, F 2015, ' Donation intensity and metabolic syndrome in active whole-blood donors ', Vox Sanguinis, vol. 109, no. 1, pp. 25-34 . https://doi.org/10.1111/vox.12258
Vox Sanguinis, 109, 1, pp. 25-34
Vox Sanguinis, 109(1), 25-34. Wiley-Blackwell

Item does not contain fulltext BACKGROUND AND OBJECTIVES: Increased iron and metabolic syndrome (MetS) go hand in hand. Frequent blood donation depletes iron stores. This study investigates whether high-intensity blood donation is associated with low

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22d071c92f25ab898690252e9305aa5f
https://doi.org/10.1111/vox.12258

Cetuximab Reduces the Accumulation of Radiolabeled Bevacizumab in Cancer Xenografts without Decreasing VEGF Expression

Autor: Otto C. Boerman, Hanneke W. M. van Laarhoven, Sandra Heskamp, Mallory S. Engelhardt, Janneke D.M. Molkenboer-Kuenen, Anneke Geurts-Moespot, Fred C.G.J. Sweep, Winette T. A. van der Graaf, Wim J.G. Oyen

Publikováno v: Molecular Pharmaceutics, 11, 4249-4257
Molecular Pharmaceutics, 11, pp. 4249-4257
Molecular pharmaceutics, 11(11), 4249-4257. American Chemical Society

Item does not contain fulltext Introduction: Bevacizumab and cetuximab are approved for the treatment of cancer. However, in advanced colorectal cancer, addition of cetuximab to chemotherapy with bevacizumab did not improve survival. The reason for t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4694f05f156b7674ec907939f29721da
https://doi.org/10.1021/mp500460g